Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
O60671
UPID:
RAD1_HUMAN
Alternative names:
DNA repair exonuclease rad1 homolog; Rad1-like DNA damage checkpoint protein
Alternative UPACC:
O60671; O75572; O95304; Q1W161; Q5KSM0; Q5KSM1; Q9UEP1
Background:
Cell cycle checkpoint protein RAD1, also known as DNA repair exonuclease rad1 homolog and Rad1-like DNA damage checkpoint protein, is a key component of the 9-1-1 cell-cycle checkpoint response complex. This complex plays a pivotal role in DNA repair, being recruited to DNA lesions upon damage. It acts as a sliding clamp platform for several proteins involved in long-patch base excision repair (LP-BER), thereby facilitating DNA polymerase beta activity, endonuclease FEN1 cleavage activity, and DNA ligase I activity on repair substrates.
Therapeutic significance:
Understanding the role of Cell cycle checkpoint protein RAD1 could open doors to potential therapeutic strategies.